UCP1 and Obesity: The mechanism by which BJ reduces obesity may be partly due to its inhibitory effects on the expression of TBK1 and IKKε, and may occur through two different pathways: the TBK1/AMPK/UCP1 pathway and the IKKε/adrenergic/cAMP pathway.